Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Screening: prerequisites].

M Hoffmeister1, U Haug, H Brenner

  • 1Abteilung Klinische Epidemiologie und Alternsforschung, Deutsches Krebsforschungszentrum, Bergheimer Strasse 20, 69115, Heidelberg, Germany. m.hoffmeister@dkfz.de

Der Internist
|April 9, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-operative C-reactive protein as a strong independent predictor of long-term colorectal cancer outcomes: consistent findings from two large patient cohorts.

ESMO open·2024
Same author

Genome-wide association studies and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Sensitivity of a blood ctDNA-based multimodal test for the detection of advanced colorectal neoplasms.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study.

Vaccine·2022
Same author

Artificial intelligence for detection of microsatellite instability in colorectal cancer-a multicentric analysis of a pre-screening tool for clinical application.

ESMO open·2022
Same author

Correction: Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years.

Molecular psychiatry·2021
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Disease screening is effective for prevention and treatment but requires specific conditions. Early detection must improve outcomes, outweighing potential harms like false positives and over-diagnoses, all within acceptable costs.

Area of Science:

  • Public Health
  • Preventive Medicine
  • Diagnostic Testing

Context:

  • Screening programs are crucial for disease prevention and management.
  • Effective screening requires careful consideration of prerequisites for successful implementation.
  • The potential benefits of early disease detection must be weighed against possible harms.

Purpose:

  • To outline the essential criteria for successful disease screening programs.
  • To emphasize the importance of scientific evidence in guiding screening implementation.
  • To highlight the need for rigorous evaluation of screening initiatives.

Summary:

  • Screening is a powerful tool for disease prevention and treatment, but only if specific prerequisites are met.
  • Diseases must have a detectable preclinical phase, and early detection must lead to improved health outcomes, not just prolonged illness.

Related Experiment Videos

  • The benefits of screening, including improved patient outcomes and cost-effectiveness, must outweigh potential harms such as false positives and over-diagnoses.

    • Impact:

    • Informs the development and implementation of evidence-based screening programs.
    • Enhances the effectiveness of public health strategies for disease prevention.
    • Contributes to optimizing healthcare resource allocation for maximum patient benefit.